Business
Helix BioPharma Corp. Announces Voting Results from its Annual General and Special Meeting
(TheNewswire)   Toronto, Ontario – TheNewswire - 30 January, 2026 – ...
About this update from Helix Biopharma Corp.
[{"type":"text","content":"Helix BioPharma Corp. Announces Voting Results from its Annual General and Special Meeting \n(TheNewswire)\n\n\n\n \n\n\nToronto, Ontario – TheNewswire\n- 30 January, 2026 – Helix BioPharma Corp.\n(TSX: “HBP”, OTC: “HBPCF”, FRANKFURT: “HBP0”)\n(“Helix” or the “Company”), a clinical-stage oncology\ncompany shaping a near future where today’s hard-to-treat cancers\nare vincible, is pleased to announce the voting results from the\nAnnual General and Special Meeting of its Shareholders (the\n“Meeting”) held on Friday, January 30, 2026. A total of 61,885,815\ncommon shares were voted at the Meeting, representing 81.03 % of\nHelix’s total issued and outstanding shares.\n\n\n \n\n\nShareholders voted overwhelmingly in favor of all items\nof business before the Meeting. The four director nominees listed in\nHelix’s Management Information\nCircular (the “Information Circular”) dated December 15, 2025, were re-elected as directors of\nthe Company to hold office for the ensuing year or until their\nsuccessors are elected or appointed. The detailed results of the vote\nfor each director are set out below:  \n\n\n \n\n \n\n\nJacek Antas\n\n\n\n\nJerzy Leszczynski\n\n\n\n\nJanusz Grabski\n\n\n\n\nMalgorzata Laube\n\n\n \n\n\n#\n\n\n\n\n%\n\n\n\n\n#\n\n\n\n\n%\n\n\n\n\n#\n\n\n\n\n%\n\n\n\n\n#\n\n\n\n\n%\n\n\n\n\nVotes in Favor\n\n\n\n\n61,885,252\n\n\n\n\n99.99%\n\n\n\n\n61,885,812\n\n\n\n\n99.99%\n\n\n\n\n61,885,792\n\n\n\n\n99.99%\n\n\n\n\n61,885,792\n\n\n\n\n99.99%\n\n\n\n\nVotes Withheld\n\n\n\n\n563\n\n\n\n\n00.01%\n\n\n\n\n3\n\n\n\n\n00.01%\n\n\n\n\n23\n\n\n\n\n00.01%\n\n\n\n\n23\n\n\n\n\n00.01%\n\n\n\n\n \n\n\nThe resolutions to appoint Clearhouse LLP as auditor of\nHelix BioPharma until the next annual general meeting at remuneration\nto be determined by the directors, were approved with 99.99% of the\nvotes cast in favor. \n\n\n \n\n\nThe resolution regarding the amendment to the articles of the Company to effect a consolidation of the\nissued and outstanding common shares on the basis of a consolidation\nratio selected by the directors of the Company of up to five (5)\npre-consolidation common shares for one (1) post-consolidation common\nshare, and to authorize t...